International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 193-199 doi: 10.5281/zenodo.16527581
Original Article
Correlation of TIMI Score and Killip Class with MACE In Non ST Elevation Myocardial Infarction
 ,
 ,
 ,
 ,
Published
July 28, 2025
Abstract

OBJECTIVES: Non-ST-elevation myocardial infarction (NSTEMI) constitutes  a significant proportion of acute coronary syndromes (ACS) and is a leading cause of morbidity and mortality worldwide.  TIMI score and Killip class are easily obtained clinical parameters to predict MACE . The objective of this study is to assess the correlation of TIMI score and Killip class  with MACE  in Non ST elevation myocardial  infarction

METHODS : The study included 154 patients who presented to the Department of Cardiology, NEIGRIHMS, Shillong with NSTEMI . Non-STEMI  myocardial infarction is character­ized by abnormal cTnI ≥ 0.04 ng/ml.  A 12-lead ECG was performed at admission in all cases and then at 6, 12, 18, 24 and 48 h post-admission.  Blood samples were obtained after ≥ 6 hours since the beginning of the last episode of chest pain to assess cTnT .TIMI score and Killip class was calculated on admission . Major clinical events (MCE) observed up to 30 days post-dis­charge and considered as composite endpoint are: cardiac death, non-fatal myocardial and recurrent angina which led to ci­ne coronary angiography, and according to the results, the ensuing urgent revascularization treatment within 30 days of admis­sion. Patients were divided into two groups according to the presence (group A) or absence (group B) of MACE . A ROC curve was generated to relate the TIMI score and Killip class  with major cardiovascular events Sensitivity, specificity and positive predictive value was estimated for TIMI score and Killip classification    for presence or absence of major cardiovascular events.

RESULTS: The mean TIMI score in patients with MACE  was 3.76±0.75  and  was significantly higher  in patients without MACE 2.24±0.84 (p≤0.001).

In 33 of the 38 patients with MACE   the TIMI SCORE was more than 2 while 51 of the 116 patients without MACE had TIMI SCORE>2. The number of  patients with TIMI SCORE>2 had significantly higher rate of MACE . (p≤0.001).

28 OF THE 38 patients with MACE had KILLIP CLASS > 1 ; while 15 of 116 patients without MACE had KILLIP CLASS > 1. The number of  patients with KILLIP CLASS > 1had significantly higher rate of MACE . (p=0.004).

CONCLUSION: There is a significant  correlation between TIMI score and Killip Class  in prognosis of patients with Non ST elevation Myocardial Infarction   . TIMI score and Killip class are easily available tools to predict  MACE

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1517 Views
418 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved